top of page
H1.jpg
FONDO V2_3x.png

deserve modern

disease screening 

All Women

Worldwide

The Pap smear, the most common screening tool for cervical cancer, is almost 100 years old. It’s also expensive, painful, time-consuming from sample to diagnosis, and employs antiquated technology. 

With regular screening and follow-up care, cervical cancer is the most preventable form of cancer affecting women today. However, current forms of testing and diagnosis are outdated and ineffective. 

DOTS 3_3x.png
DOTS 3_3x.png
HERAFEM DEVICE.png

Introducing

The study is completed during the time of the consultation.

BENEFITS HERA (3).png

No

Laboratory

Required

Obtaining results in minutes, during the consultation.

Real

Time

Results

BENEFITS HERA (1).png

Attributes

Accuracy in tissue reading above 90%, surpassing the low percentage (40%) offered by the current Pap Smear test.

Accurate

BENEFITS HERA (2).png

Affordable prices to allow all women, everywhere, the access to modern screening tests that can save their lives.

Affordable

BENEFITS HERA (4).png

Combining advanced spectroscopy methods with data insights and 
Artificial Intelligence algorithms

Delivers accurate cervical cancer diagnoses
in real time.

H3.jpg

The future in cervical
cancer diagnostics is

here

bottom of page